Kistler-Tiffany Companies’s Agios Pharmaceuticals AGIO Stock Holding History

Kistler-Tiffany Companies’s Portfolio AGIO Stock Details AGIO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q2	–	Sell	-25	Closed	-$1K	–	629
2016 Q1	$1K	Hold	25	–	–	﹤0.01%	533
2015 Q4	$2K	Hold	25	–	–	﹤0.01%	542
2015 Q3	$2K	Hold	25	–	–	﹤0.01%	547
2015 Q2	$3K	Hold	25	–	–	﹤0.01%	530
2015 Q1	$2K	Sell	25 -123	-83%	-$13.8K	﹤0.01%	530
2014 Q4	$17K	Buy	+148	New	+$13.2K	0.01%	384

Other funds holding AGIO

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

BB Biotech Schaffhausen, Switzerland $3.98B AUM 15.47% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

FV2GP

Flagship Ventures 2007 General Partner Cambridge, Massachusetts $107M AUM

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Kistler-Tiffany Companies's AGIO Position: Q2 2016 in Review

Kistler-Tiffany Companies sold out of Agios Pharmaceuticals (AGIO) in Q2 2016, closing a stake of 25 shares — an estimated $1K sold.

Kistler-Tiffany Companies first reported a position in AGIO in Q4 2014 and held it in 6 quarters. The position peaked at $17K in Q4 2014. 155 funds tracked by Wall St. Rank hold AGIO as of Q2 2016.

Kistler-Tiffany Companies reported no remaining Agios Pharmaceuticals position as of Q2 2016 after selling out during the quarter.
Kistler-Tiffany Companies sold 25 Agios Pharmaceuticals shares in Q2 2016, an estimated $1K.
Kistler-Tiffany Companies first reported a position in Agios Pharmaceuticals in Q4 2014 and held it in 6 quarters.
Kistler-Tiffany Companies's Agios Pharmaceuticals position peaked at $17K in Q4 2014.
155 funds tracked by Wall St. Rank held Agios Pharmaceuticals as of Q2 2016.

Based on Kistler-Tiffany Companies's 13F filing for Q2 2016, filed 6 Jul 2016.